Canada markets close in 4 hours 36 minutes

eFFECTOR Therapeutics, Inc. (EFTRW)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.0290-0.0046 (-13.69%)
As of 10:29AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.52
52-Week Change 3N/A
S&P500 52-Week Change 322.38%
52 Week High 30.0290
52 Week Low 30.0290
50-Day Moving Average 3N/A
200-Day Moving Average 3N/A

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5N/A
Implied Shares Outstanding 6N/A
Float 83.59M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends N/A
Most Recent Quarter (mrq)N/A

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.26%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -33.73M
Net Income Avi to Common (ttm)-35.81M
Diluted EPS (ttm)-0.9050
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)18.37M
Total Cash Per Share (mrq)4.98
Total Debt (mrq)20.55M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.77
Book Value Per Share (mrq)-9.52

Cash Flow Statement

Operating Cash Flow (ttm)-29.55M
Levered Free Cash Flow (ttm)-17.73M